Market likes Amerisur 's Colombia acquisition
Some of the main risers and fallers at 3.45pm: Amerisur Resources, PCG Entertainment
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 12 of 15
Allergy Therapeutics recruits first patients to its phase III birch trial
The year-long study over 50 sites in Germany, Sweden, Austria and Poland
Investments and investor services
FTSE 100, 250 and smallcaps all mark record highs after Fed rate hike and cap
FTSE 100 stocks ended solidly higher on Thursday after chalking a fresh record high as investors reacted to a tempered rate hike outlook in the US and relief at the defeat of the anti-immigration Freedom party in the Dutch election
Archive
Proactive news round-up: Allergy Therapeutics, Sunrise Resources, KEFI Minerals ...
A glance at some of the stories on the Proactive newswire today.
Allergy Therapeutics launches phase I trial of dust mite inoculation
A total of 32 patients will receive Acarovac MPL. The trial is expected to take 12 months from start to finish.
FTSE 100 shares slid despite high-flying Tui
The FTSE 100 just didn’t travel on Tuesday as the blue-chip ticker gave up light gains to end lower despite bumper results from travel firm Tui
Archive
Proactive news summary: Keywords confirms sparkling 2016
Also featured: Allergy Therapeutics, DP Poland, Eckoh, Harvest Minerals, Metal Tiger, Scotgold Resources, Sound Energy
Allergy Therapeutics unveils new non-executive director
Jean-Yves Pavee retired from the board last night and has been replaced by Jeff Barton, who has been nominated by Abbott Laboratories.
Allergy Therapeutics peanut allergy vaccine to move into phase I trials after pre-clinical success
The company is developing Polyvac as a short course of injections that is safer and more effective than the current treatments.
Archive
Proactive news highlights: Featuring Sound Energy; Shanta Gold, Allergy Therapeutics and more…
Sound Energy’s latest Morocco well flowed close to a billion cubic feet of gas during tests; Shanta Gold said it’s ahead of both cost and production targets; plus much more…
Not to be sneezed at - Allergy Therapeutics revenues up 18%
The company, which has developed short course inoculations against hay fever, said turnover was £40.4mln in the six months ended December 31.
Archive
Proactive news round-up: Satellite Solutions Worldwide, C4X Discovery, Tissue Regenix …
A glance at some of the stories on the Proactive newswire today
Broker 'nuts' about Allergy Therapeutics; reckons stock could double in value
Initiating coverage of the vaccines business, finnCap set a price target of 40p a share based on its analysis of the company’s peer group.
Proactive news highlights: BATM, Victoria Oil & Gas, Allergy Therapeutics
BATM secures a contract down under; Victoria Oil & Gas starts development drilling in Cameroon; Allergy Therapeutics secures European patent; plus much more
Risers and fallers: Next, Sirius Minerals, Victoria Oil & Gas
Shares in Victoria Oil & Gas were up after it spudded two development wells at its Logbaba gas field in Cameroon
Proactive news round-up: Eurasia Mining, Scancell, Metal Tiger ...
A glance at today's Proactive small -cap stories from the newswire
Allergy Therapeutics' malaria boost
The firm's scientists used what’s called an adjuvant, which enhances the body’s immune response to an illness or disease.
Riser and fallers: UK Mail Group, Allergy Therapeutics, Easyhotel...
German courier giant Deutsche Post DHL Group has agreed to acquire UK Mail for more than £240mln
FTSE 100 shares end higher, led by commodity-related stocks
FTSE 100 stocks ended higher on Wednesday after a see-saw session, after recovering from a bout of downside this week on the fate of Germany’s biggest lender Deutsche Bank when commodity-related shares advanced